These forums have been archived and are now read-only.

The new forums are live and can be found at https://forums.eveonline.com/

Market Discussions

 
  • Topic is locked indefinitely.
 

Antipharmakon Aeolis obviating standard mindflood value
Author
Previous Topic Next Topic
Zytiga Abiraterone
Amok.
Goonswarm Federation
#1 - 2017-06-27 02:42:03 UTC
Dear CCP,

Please note the arrival of the Project Discovery Antipharmakon has caused an unfair, in my opinion, downward pressure on standard mindflood boosters.

All of the Antipharmakon boosters improve abilities with NO side effects. The increase in attributes to armor repair or shield boosts they provide are 8% compared to the standard exile and blue pill +20%. The conventional standard boosters add a level of benefit albeit with risk of side effects.

https://wiki.eveuniversity.org/Medical_boosters

However, if you look at the capacitor booster, Antipharmakon Aeolis, which adds + 8% to capacitor with NO side effects, it is actually close to the Standard Mindflood of +10% with all the risks of side effects. This has put unfair pressure on the price of Standard Mindflood. As you can see on the market, the price has dropped to 1.6 mil compared to Standard Exile/Blue pill which remains close to 2.6-3 mil since the beginning of the year.

If the Antipharmakon Aeolis continues to be available, the booster benefits should be adjusted based on the risks/benefit ratio previously established.





Sabriz Adoudel
Move along there is nothing here
#2 - 2017-06-27 12:25:51 UTC
Game changes smashing up existing markets is normal.

Modulated Strip Miner II is still in the dumpster (pricewise) since the Rorqual buffs.

Any market has this inherent risk in it.

I support the New Order and CODE. alliance. www.minerbumping.com